Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← AKO Capital, latest 13F

Thermo Fisher Scientific

In AKO Capital's portfolio · London

Ticker TMO

Not in the portfolio as of Q3 2026. Every quarter it shows up in a London 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q3 2025 Sell 0  
Q2 2025 Reduce 92% 26,427 0.1% $405.46 $10.7M
Q1 2025 Add 6% 332,845 2.1% $497.60 $165.6M
Q4 2024 Reduce 26% 313,784 2.3% $520.23 $163.2M
Q3 2024 Reduce 19% 423,473 3.4% $618.57 $261.9M
Q2 2024 Add 14% 524,248 4.0% $553.00 $289.9M
Q1 2024 Add 181% 460,183 3.8% $581.21 $267.5M
Q4 2023 Reduce 52% 163,937 1.2% $530.79 $87.0M
Q3 2023 Reduce 2% 338,427 2.8% $506.17 $171.3M
Q2 2023 Reduce 44% 345,573 2.7% $521.75 $180.3M
Q1 2023 Reduce 5% 614,284 5.4% $576.37 $354.1M
Q4 2022 Reduce 30% 647,343 5.8% $550.69 $356.5M
Q3 2022 Reduce 24% 924,031 7.7% $507.19 $468.7M
Q2 2022 No change 1,212,500 9.2% $543.28 $658.7M
Q1 2022 Reduce 2% 1,206,538 7.7% $590.65 $712.6M
Q4 2021 Add 8% 1,229,899 8.0% $667.24 $820.6M
Q3 2021 Add 16% 1,142,461 6.8% $571.33 $652.7M
Q2 2021 Add 34% 984,437 5.6% $504.47 $496.6M
Q1 2021 Add 39% 735,859 4.2% $456.38 $335.8M
Q4 2020 Add 22% 529,274 3.2% $465.78 $246.5M
Q3 2020 Buy 435,377 3.0% $441.52 $192.2M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.